Tailoring Treatment of EGFR-Mutated NSCLC to Improve Patient Care, Oct 24

Memo

Join us on Wednesday, October 24 at the Orlando World Center Marriott for this interactive symposium where pharmacy and oncology experts Val R. Adams, PharmD, FCCP, BCOP; Edward S. Kim, MD, FACP; and Philip Schwieterman, PharmD, MHA, provide their perspectives on the role of EGFR-targeted therapies in the management of patients with advanced EGFR-mutated NSCLC, including insights into the latest first-line and second-line clinical data and how pharmacists can safely and effectively apply these new practice-changing data into care plans for their patients. This satellite symposium is complimentary to attend and is ACPE-certified for 1.5 contact hours. For more information and to register, visit our site here: https://events.clinicaloptions.com/oncology/Nexus2018. Speakers: Val R. Adams, PharmD, FCCP, BCOP, Edward S. Kim, MD, FACP, Philip Schwieterman, PharmD, MHA Time: 6:00 pm - 8:00 pm Venue details: Orlando World Center Marriott,8701 World Center Drive,Canary 1-2, Orlando, 32821, USA